Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125,600 | 36 | 68.2% |
| Consulting Fee | $26,903 | 11 | 14.6% |
| Travel and Lodging | $20,291 | 40 | 11.0% |
| Honoraria | $8,050 | 3 | 4.4% |
| Food and Beverage | $3,316 | 51 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $108,367 | 70 | $0 (2023) |
| Janssen Biotech, Inc. | $39,825 | 35 | $0 (2022) |
| InSightec,Inc | $18,410 | 10 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $5,474 | 5 | $0 (2019) |
| Progenics Pharmaceuticals, Inc. | $4,438 | 3 | $0 (2023) |
| Beckman Coulter, Inc. | $3,693 | 4 | $0 (2017) |
| Janssen Global Services, LLC | $2,246 | 2 | $0 (2024) |
| PFIZER INC. | $1,050 | 1 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $371.37 | 5 | $0 (2017) |
| Boston Scientific Corporation | $125.49 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,246 | 2 | Janssen Global Services, LLC ($2,246) |
| 2023 | $6,103 | 4 | Progenics Pharmaceuticals, Inc. ($3,088) |
| 2022 | $10,594 | 12 | Janssen Scientific Affairs, LLC ($5,297) |
| 2021 | $2,366 | 4 | Janssen Biotech, Inc. ($1,303) |
| 2020 | $7,750 | 6 | InSightec,Inc ($4,000) |
| 2019 | $34,861 | 24 | Janssen Biotech, Inc. ($19,201) |
| 2018 | $105,728 | 70 | Janssen Scientific Affairs, LLC ($95,955) |
| 2017 | $14,512 | 19 | Janssen Biotech, Inc. ($6,152) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| 11/23/2024 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $220.97 | General |
| 12/22/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/14/2023 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $2,880.00 | General |
| 11/28/2023 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 07/13/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $488.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/07/2022 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $2,880.00 | General |
| 11/29/2022 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $129.99 | General |
| 11/29/2022 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 11/15/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $1,010.00 | General |
| Category: Oncology | ||||||
| 08/20/2022 | Boston Scientific Corporation | General - Male SUI (Device) | Food and Beverage | In-kind items and services | $125.49 | General |
| Category: General - Male SUI_URO | ||||||
| 06/21/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 04/25/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 03/09/2022 | Profound Medical Corp. | Tulsa-Pro (Device) | Food and Beverage | Cash or cash equivalent | $94.48 | General |
| Category: Device | ||||||
| 01/22/2022 | Coloplast Corp | Titan (Device) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Men's Health | ||||||
| 01/11/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 01/06/2022 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $2,170.00 | General |
| Category: Oncology | ||||||
| 01/06/2022 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $96.74 | General |
| Category: Oncology | ||||||
| 12/09/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $103.38 | General |
| Category: Oncology | ||||||
| 07/28/2021 | PFIZER INC. | GELFOAM (Device) | Honoraria | Cash or cash equivalent | $1,050.00 | General |
| Category: HEMOSTAT | ||||||
| 05/19/2021 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Men's Health | ||||||
| 05/03/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Oncology | ||||||
| 08/26/2020 | InSightec,Inc | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 08/17/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Oncology | ||||||
| 07/02/2020 | Progenics Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 512 | 538 | $489,991 | $48,270 |
| 2022 | 10 | 575 | 620 | $555,963 | $64,974 |
| 2021 | 8 | 544 | 592 | $501,183 | $62,142 |
| 2020 | 8 | 504 | 521 | $420,116 | $49,441 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 20 | 20 | $217,318 | $20,248 | 9.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 185 | 194 | $71,557 | $8,950 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 90 | 91 | $61,434 | $7,475 | 12.2% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 20 | 20 | $105,702 | $5,926 | 5.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 118 | 132 | $18,492 | $3,166 | 17.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 55 | 55 | $11,271 | $1,476 | 13.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 11 | 11 | $3,696 | $902.55 | 24.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 15 | $522.00 | $126.00 | 24.1% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 24 | 24 | $261,983 | $30,541 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 194 | 210 | $66,722 | $10,120 | 15.2% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2022 | 23 | 23 | $117,828 | $7,724 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 78 | 82 | $53,528 | $6,303 | 11.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 133 | 156 | $20,880 | $3,934 | 18.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 44 | 46 | $10,087 | $2,009 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 12 | $6,460 | $1,381 | 21.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 15 | 15 | $4,788 | $1,178 | 24.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 39 | 39 | $8,669 | $1,048 | 12.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 13 | 13 | $5,019 | $738.10 | 14.7% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2021 | 21 | 21 | $221,052 | $27,405 | 12.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 192 | 216 | $70,783 | $11,138 | 15.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 104 | 108 | $62,689 | $8,902 | 14.2% |
| 38571 | Removal of total lymph nodes of both sides of pelvis using an endoscope | Facility | 2021 | 21 | 21 | $105,060 | $6,410 | 6.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 104 | 122 | $15,814 | $2,783 | 17.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 52 | 53 | $11,253 | $2,524 | 22.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 25 | 25 | $7,695 | $2,180 | 28.3% |
About Scott Eggener
Scott Eggener is a Urology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548440027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Scott Eggener has received a total of $184,160 in payments from pharmaceutical and medical device companies, with $2,246 received in 2024. These payments were reported across 141 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($125,600).
As a Medicare-enrolled provider, Eggener has provided services to 2,135 Medicare beneficiaries, totaling 2,271 services with total Medicare billing of $224,827. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Los Angeles, CA
- Active Since 11/13/2007
- Last Updated 01/30/2026
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1548440027
Products in Payments
- Erleada (Drug) $124,965
- ERLEADA (Drug) $11,030
- LYNPARZA (Drug) $5,474
- DxI 600 (Device) $3,693
- PYLARIFY (Drug) $3,088
- GELFOAM (Device) $1,050
- NO PRODUCT DISCUSSED (Drug) $371.37
- General - Male SUI (Device) $125.49
- Tulsa-Pro (Device) $94.48
- SPEEDICATH (Device) $35.92
- Titan (Device) $29.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Los Angeles
Mihir Desai, M.d, M.D
Urology — Payments: $1.6M
Arie Belldegrun, Md, MD
Urology — Payments: $1.3M
Dr. William Aronson, Md, MD
Urology — Payments: $753,306
Dr. Stuart Holden
Urology — Payments: $668,127
Dr. Siamak Daneshmand, M.d, M.D
Urology — Payments: $317,876
Dr. Jeffrey Loh-Doyle, M.d, M.D
Urology — Payments: $295,721